The Randstad, Netherlands
EXECUTIVE SUMMARY I take on C-level roles in technology companies that need order, stability, and growth restored, and I work inside the business to do it, hands-on and alongside the team, not from a distance with slide decks. A turnaround is a human problem before it is a financial one. I walk into organizations that have lost belief and give people a reason to perform again, across cultures and across continents. I have rebuilt and motivated teams in Rotterdam, Manchester, Potsdam, Seattle, Dubai, and across the United States, China, India, and Europe. The commercial recovery follows from there. My playbook was built in the hardest commercial environment there is. In global MedTech and health AI, pressure and risks are high, products are complex, sales cycles run for years, regulators hold the gate, and only deep expertise and trust win the deal. That same playbook travels to any deep-tech market with those characteristics, which is why it now also transfers into HR and Psych tech. Selected results: 78% revenue recovery at French AI clinical applications public company, 300% pipeline growth in 12 months at Scale-up, 250% backlog growth with 25 to 50% cost reduction at MedTech company, and record revenue with 300%+ new-business growth at a Dutch public healthcare company. Co-founder of the world's first patient digital twin platform in Seattle WA USA and founder of a global healthcare AI marketplace. I have also codified what makes individuals and teams perform into the Prime Potential leadership genome platform, so the team building is method, not intuition. SELECTED ENDORSEMENTS His ability to grasp personality and almost every quirk in the very first conversation, and then give pointed advice, is extraordinary. Priya Sampath, Corporate Counsel (client, 2026) One of those rare executives who also naturally serves as an inspiring mentor for the whole company, able to motivate a team and be a key success factor in the result. Kevin Stouten, direct report, Bioxydyn Energetic, highly enthusiastic, with excellent interpersonal skills. Gets things done fast and accurately. Prof. Tim Leiner, MD PhD, Radiology, Mayo Clinic
The executive your AI company needs right now in your High Pressure, High Risk, High Reward SME. 25+ Years commercial leadership with 15+ Companies built or transformed companies in North America, Europe, Middle East, India, and China. I know this world, not from a business school case study, but from 20+ years of high-velocity execution in the trenches. AI-driven tech companies rarely fail because the technology isn't ready; they fail because the commercial engine is stalled. I bring the high-octane leadership and veteran energy needed to bridge the gap between breakthrough innovation and market reality. My focus is razor-sharp on the pillars where most ventures falter: securing Product-Market Fit and validating Willingness to Pay. Under extreme pressure, team dynamics are often the first to fracture. I specialize in maximizing team performance when the stakes are highest, turning friction into focus and ensuring leadership, engineering, and sales move as one cohesive unit. I don't just build strategies; I build the momentum that wins.
HTA Based Product - Market fit re-positioning. Managing the Go-To-Market, KOL projects, regulatory approvals, compliance and reimbursement strategies.
AI-powered cardiac scanning technology with stalled commercialization. Broke through the impasse, orchestrated a strategic turnaround, and delivered measurable commercial traction. Responsible for clinical value creation, health technology assessment, and go-to-market execution.
An executive leadership assessment platform that I built over the past years to systematize twenty years of human interaction observation. The framework integrates twelve psychometric instruments into two structured tools: Leadership Genome™ for individual leaders, and Team Genome™ for assessing how multiple profiles function together in an organizational hierarchy. Most leadership development fixes the visible. The harder work , the patterns, blind spots and unlocked potential that determine whether a leader plateaus or transforms, and the systemic dynamics that determine whether a team produces or fractures, is where this practice focuses. Used in my own engagements at HPBE. Client confidentiality is absolute; the platform itself (prime-potential.com) operates on a self-funded basis.
Co-founded a healthcare technology company specializing in digital twins for personalized patient care. Developed patient-specific simulations utilizing virtual replicas based on physiological characteristics, medical history, and genetic information. Innovated healthcare solutions by using digital twins to forecast disease progression, simulate treatment effects, and provide real-time outcome feedback. Differentiated Twinome Health through a dynamic approach that constantly integrates new patient data into digital twins for enhanced accuracy and personalization. Spearheaded a longitudinal approach at Twinome Health, monitoring patients throughout their treatment journey to optimize care and outcomes. Recognized as a global thought leader in Patient Digital Twins, and one of the 80 thought leaders at the first Virtual Human Global Summit in 2023 in New York.
Spearheaded the creation of Vigor as Founder & CEO, driving the mission to simplify and amplify AI adoption in healthcare. Established an independent, curated marketplace on a global platform to accelerate decision-making and streamline implementation of cutting-edge AI solutions. Ensured scalability, quality, and affordability as core pillars for healthcare professionals accessing AI technologies. Pioneered the next healthcare innovation wave.
Spearheaded the start, development and initial growth of a groundbreaking solution for early osteoporosis detection. Secured multimillion-dollar investments through public and private funding rounds at regional, national, and European levels. Established a strong financial foundation to bring the innovation to market. Made the decision to step down as Co-Founder & CEO to focus on new opportunities and future ventures in the Netherlands.